Literature DB >> 17898548

[The role of activated hepatic stellate cells in liver fibrosis, portal hypertension and cancer angiogenesis].

June Sung Lee1, Jong Hoon Kim.   

Abstract

Although hepatic stellate cells, which are liver specific pericytes, have been recognized within the vasculature of the sinusoid for more than one hundred years, the biology and function of these cells is unclear. Recent studies have highlighted the key role of stellate cells in a number of fundamental processes that include wound healing/fibrosis, vasoregulation, and vascular remodeling/angiogenesis. In the liver, these processes are particularly important in the development of cirrhosis, portal hypertension and cancer. This article highlights the recent advances in our understanding of the biology of hepatic stellate cells and discusses some of the recently-ascribed functions that are relevant to liver fibrosis, portal hypertension and cancer angiogenesis.

Entities:  

Mesh:

Year:  2007        PMID: 17898548     DOI: 10.3350/kjhep.2007.13.3.309

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  8 in total

1.  Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension.

Authors:  Ali Amin; Soo-Kyoung Choi; Yehia Osman-Elazeik; Nariman K Badr El-Din; Christopher G Kevil; Louis G Navar; Philip Kadowitz; Mohamed Trebak; Khalid Matrougui
Journal:  Pflugers Arch       Date:  2012-10-07       Impact factor: 3.657

2.  Ductular reaction promotes intrahepatic angiogenesis through Slit2-Roundabout 1 signaling.

Authors:  Mar Coll; Silvia Ariño; Celia Martínez-Sánchez; Ester Garcia-Pras; Javier Gallego; Anna Moles; Beatriz Aguilar-Bravo; Delia Blaya; Julia Vallverdú; Teresa Rubio-Tomás; Juan Jose Lozano; Elisa Pose; Isabel Graupera; Andrea Fernández-Vidal; Albert Pol; Ramón Bataller; Jian-Guo Geng; Pere Ginès; Mercedes Fernandez; Pau Sancho-Bru
Journal:  Hepatology       Date:  2021-12-15       Impact factor: 17.425

3.  Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells.

Authors:  Qing-An Jia; Zhi-Ming Wang; Zheng-Gang Ren; Yang Bu; Xiao-Ying Xie; Yan-Hong Wang; Lan Zhang; Qiang-Bo Zhang; Tong-Chun Xue; Li-Fen Deng; Zhao-You Tang
Journal:  BMC Complement Altern Med       Date:  2013-04-27       Impact factor: 3.659

4.  The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.

Authors:  Yang Bu; Qing-An Jia; Zheng-Gang Ren; Tong-Chun Xue; Quan-Bao Zhang; Ke-Zhi Zhang; Qiang-Bo Zhang; Yang You; Hui Tian; Lun-Xiu Qin; Zhao-You Tang
Journal:  Oncotarget       Date:  2015-11-24

Review 5.  Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?

Authors:  Kai Qu; Tian Liu; Ting Lin; Xing Zhang; Ruixia Cui; Sinan Liu; Fandi Meng; Jingyao Zhang; Minghui Tai; Yong Wan; Chang Liu
Journal:  Oncotarget       Date:  2016-10-11

6.  Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive.

Authors:  Bing Han; Huan Tang; Qiming Liang; Ming Zhu; Yizhuo Xie; Jinglin Chen; Qianwen Li; Juan Jia; Yan Li; Zhihui Ren; Dengli Cong; Xiaofeng Yu; Dayun Sui; Jin Pei
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 7.  Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?

Authors:  Can-Jie Guo; Qin Pan; Hua Xiong; Yu-Qi Qiao; Zhao-Lian Bian; Wei Zhong; Li Sheng; Hai Li; Lei Shen; Jing Hua; Xiong Ma
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

Review 8.  New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials.

Authors:  Kai Qu; Zichao Huang; Ting Lin; Sinan Liu; Hulin Chang; Zhaoyong Yan; Hongxin Zhang; Chang Liu
Journal:  Front Pharmacol       Date:  2016-01-18       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.